Rashtriya Newsflash

Fibromyalgia Market: Expanding Revenue Landscape to 2034 – DelveInsight | UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma, Tonix Pharma, UCB Biopharma SRL, GSK, UCB Pharma

Fibromyalgia Market: Expanding Revenue Landscape to 2034 – DelveInsight | UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma, Tonix Pharma, UCB Biopharma SRL, GSK, UCB Pharma

The Key Fibromyalgia Companies in the market include – Tonix Pharmaceutical, UCB Biopharma SRL, GlaxoSmithKline, UCB Pharma, Pierre Fabre Medicament, UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma,

Read Full Article

Lewy Body Dementia Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Jazz Pharma, Allergan, Noven Pharma, Takeda Pharma, Eli Lilly, Mallinckrodt

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Lewy Body Dementia pipeline constitutes key companies continuously working towards developing Lewy Body Dementia treatment therapies, analysis of Clinical Trials,

Read Full Article

Celiac Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical, Calypso Biotech

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Celiac Disease pipeline constitutes 25+ key companies continuously working towards developing 30+ Celiac Disease treatment therapies, analysis of Clinical Trials,

Read Full Article

CinDome Pharma “CIN-102” Market size expansion of Several Folds by 2034

Explore DelveInsight’s comprehensive report on CIN-102 (CinDome Pharma), offering market insights, sales forecast, and analysis through 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has

Read Full Article

TRYPTYR by Aerie Pharmaceuticals expected to drive market size of Dry Eye Disease

Explore DelveInsight’s comprehensive report on TRYPTYR (Aerie Pharmaceuticals), offering market insights, sales forecasts, and analysis of the drug landscape through

Read Full Article

Donanemab by Eli Lilly and Company expected to drive market size of Alzheimer’s Disease

Explore the comprehensive Donanemab market report by a leading healthcare research firm, offering detailed insights, sales forecasts, and market analysis

Read Full Article

Spinal Cord Injury Market: Growth Momentum Across 7MM to 2034 – DelveInsight | Kringle Pharma, Neuroplast, Abbvie, Mitsubishi Tanabe Pharma, Lineage Cell Therapeutics, NervGen Pharma

The Key Spinal Cord Injury Companies in the market include – Athersys, Olatec Therapeutics, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage

Read Full Article

Follicular Lymphoma Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Follicular Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma

Read Full Article

Fabry Disease Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Fabry Disease Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in the Fabry

Read Full Article

Artificial Intelligence in Drug Commercialization: Market Projected to Grow at 24.12% CAGR Through 2032 | DelveInsight

Artificial Intelligence (AI) in Drug Commercialization DelveInsight Business Research, a leading pharmaceutical market research and business consulting firm, has released

Read Full Article